Title : Downregulation of PGY1/MDR1 mRNA level in human KB cells by antisense oligonucleotide conjugates. RNA accessibility in vitro and intracellular antisense activity.

Pub. Date : 2002 Jun 7

PMID : 12031494






9 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Downregulation of PGY1/MDR1 mRNA level in human KB cells by antisense oligonucleotide conjugates. Oligonucleotides ATP binding cassette subfamily B member 1 Homo sapiens
2 Downregulation of PGY1/MDR1 mRNA level in human KB cells by antisense oligonucleotide conjugates. Oligonucleotides ATP binding cassette subfamily B member 1 Homo sapiens
3 Three of the tested oligonucleotide conjugates specifically inhibited the expression of PGY1/MDR1 mRNA as monitored by the RT-PCR assay. Oligonucleotides ATP binding cassette subfamily B member 1 Homo sapiens
4 Three of the tested oligonucleotide conjugates specifically inhibited the expression of PGY1/MDR1 mRNA as monitored by the RT-PCR assay. Oligonucleotides ATP binding cassette subfamily B member 1 Homo sapiens
5 The oligonucleotide conjugate targeted to the region (+178; +194) of the PGY1/MDR1 mRNA decreased level of this mRNA to 10% compared to the control. Oligonucleotides ATP binding cassette subfamily B member 1 Homo sapiens
6 The oligonucleotide conjugate targeted to the region (+178; +194) of the PGY1/MDR1 mRNA decreased level of this mRNA to 10% compared to the control. Oligonucleotides ATP binding cassette subfamily B member 1 Homo sapiens
7 Nuclease-resistant analogs of oligonucleotide, complementary to this MDR1 mRNA region therefore, might be considered as a prototype compounds for development of gene-targeted therapeutic agents for overcoming the MDR phenotype caused by the overexpression of the PGY1/MDR1 gene. Oligonucleotides ATP binding cassette subfamily B member 1 Homo sapiens
8 Nuclease-resistant analogs of oligonucleotide, complementary to this MDR1 mRNA region therefore, might be considered as a prototype compounds for development of gene-targeted therapeutic agents for overcoming the MDR phenotype caused by the overexpression of the PGY1/MDR1 gene. Oligonucleotides ATP binding cassette subfamily B member 1 Homo sapiens
9 Nuclease-resistant analogs of oligonucleotide, complementary to this MDR1 mRNA region therefore, might be considered as a prototype compounds for development of gene-targeted therapeutic agents for overcoming the MDR phenotype caused by the overexpression of the PGY1/MDR1 gene. Oligonucleotides ATP binding cassette subfamily B member 1 Homo sapiens